Search Results for: macular degeneration

Japan conditionally approves new IPS cell-based heart study

Yoshiki-Sawa-IPS-cells-stem-cells-heart-diseease

Where do things stand with IPS cell translational research? The newest development is that regulators in Japan just have given conditional approval to an Osaka University team to an induced pluripotent stem (IPS) cell-based study for ischemic heart disease. For years IPS cell-based products have been on-again off-again in active clinical study for macular degeneration, work […]

Japan conditionally approves new IPS cell-based heart study Read More »

New lawsuit includes big stem cell clinic chain, Cell Surgical Network

Walraven-Cell-Surgical-Network

Does a new lawsuit including Cell Surgical Network and its leadership as defendants pose a broad test to this entire chain of stem cell clinics, which may be the largest such affiliated clinic group in the U.S. and potentially even in the world? Will lawsuits substantially impact stem cell clinics? Lawsuits against unproven, for-profit stem cell

New lawsuit includes big stem cell clinic chain, Cell Surgical Network Read More »

Grading 3 stem cell media reports on clinical science: vision, MS, & paralysis

Rosenzweig-et-al-Nature-Medicine-2018-part-of-Fig.-1

What is stem cell media? When us scientists hear the phrase “stem cell media” we usually think about the liquid food that we feed our stem cells in the lab, which resembles a kind of nutrient-rich Kool-aid, but another kind of stem cell media consists of the news coverage of stem cells. This other kind

Grading 3 stem cell media reports on clinical science: vision, MS, & paralysis Read More »

Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives

Takahashi-IPS-transplant

A team of researchers at RIKEN and Kobe City Medical Center reported at a press conference today a serious adverse event in a clinical trial participant receiving an induced pluripotent stem cell (IPS cell)-based therapy for vision loss. According to Japan Times and Yahoo! Japan (in Japanese), the patient in question in the IPS cell

Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives Read More »

New lawsuit against U.S. Stem Cell also alleges blindness

stem-cells-eyes, stem cell therapy side effects.

A new stem cell clinic lawsuit has popped up and this one, like some others, relates to a patient alleging vision loss due to a non-FDA approved stem cell offering and involves U.S. Stem Cell, Inc. (formerly called Bioheart). American stem cell clinics market direct-to-consumer stem cell offerings for a whole medical dictionary’s worth of

New lawsuit against U.S. Stem Cell also alleges blindness Read More »

New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network

Cell-Surgical-Network-Founders

Two new FDA inspection reports called 483s provide fresh insights on a stem cell clinic, the network of clinics that it belongs to, and adverse events in patients. These reports detail issues the FDA found at the stem cell clinic California Stem Cell Treatment Center and its parent chain of clinics, Cell Surgical Network. The

New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network Read More »